GO:1903055 positive regulation of extracellular matrix organization: Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903055 describes any process that activates or increases the frequency, rate or extent of extracellular matrix organization, a biological_process term in the Gene Ontology.
• Positive regulation of extracellular matrix organization is driven by secreted matricellular proteins, growth factors, integrin signaling, and mechanical cues that together control matrix assembly and remodeling.
• Dysregulated positive regulation of ECM organization contributes to vascular aging, lung fibrosis, perianal fistulizing Crohn's disease, and tumor progression.
• Key regulators include SOX9, SFRP1, and matrix-directed pericellular proteolysis components that modulate collagen deposition and stiffness.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to causally test whether a candidate gene positively regulates ECM organization.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to dissect positive regulation of extracellular matrix organization in disease-relevant contexts.
Description
The Gene Ontology term GO:1903055, positive regulation of extracellular matrix organization, refers to any process that activates or increases the frequency, rate or extent of extracellular matrix organization. Extracellular matrix (ECM) organization is the dynamic assembly, deposition, and remodeling of the network of collagens, proteoglycans, glycoproteins, and associated factors that surround cells. Positive regulation of this process is therefore central to tissue development, wound healing, and homeostasis, but when it becomes excessive or misdirected it drives fibrosis, vascular stiffening, and cancer progression. Researchers study GO:1903055 to identify the secreted and intracellular signals that turn ECM assembly up or down, and to understand how these signals are corrupted in disease. For example, SOX9 accelerates vascular aging by altering ECM composition and stiffness, illustrating how a single transcriptional regulator can positively regulate ECM organization with systemic consequences. Similarly, SFRP1 inhibits lung fibroblast invasion during the transition to injury-induced myofibroblasts, showing that positive regulation of ECM organization is tightly balanced by inhibitory cues. Because ECM organization is a process rather than a single gene product, its positive regulation is distributed across many genes, pathways, and cell types. This makes GO:1903055 a powerful annotation for interpreting transcriptomic, proteomic, and functional screens, and a practical target for CRISPR-based causal studies.
positive regulation of extracellular matrix organization At A Glance
| GO ID | GO:1903055 |
|---|---|
| GO term | positive regulation of extracellular matrix organization |
| Ontology | biological_process |
| Synonym | activation of extracellular matrix organization; upregulation of extracellular matrix organization; positive regulation of extracellular matrix organization and biogenesis |
| Major function | Increases the frequency, rate or extent of extracellular matrix organization |
| Definition source | QuickGO definition: Any process that activates or increases the frequency, rate or extent of extracellular matrix organization. |
| Related process | Extracellular matrix organization (GO:0030198) |
| Regulation direction | Positive (activating or increasing) |
| Example regulators | SOX9, SFRP1, matrix-directed pericellular proteolysis components |
What Is GO:1903055?
In our own words, GO:1903055 (positive regulation of extracellular matrix organization) is the biological process by which a cell or tissue increases the frequency, rate, or extent of ECM organization. It does not describe the structural components of the matrix themselves, but rather the regulatory inputs that promote matrix assembly, deposition, crosslinking, and remodeling. These inputs can be secreted factors, cell-surface receptors, intracellular signaling cascades, or mechanical forces that ultimately enhance ECM organization.
Why Is positive regulation of extracellular matrix organization Important in Cell Biology?
Positive regulation of extracellular matrix organization is important because it sits at the intersection of normal tissue repair and major human diseases. When this process is appropriately activated, it supports wound healing, bone regeneration, and developmental morphogenesis. When it is chronically or excessively activated, it promotes vascular aging, lung fibrosis, fistulizing Crohn's disease, and tumor progression. Understanding which genes positively regulate ECM organization, and how, is therefore essential for identifying therapeutic targets and for interpreting genome-wide screens.
• Controls ECM deposition and stiffness during vascular aging and cardiovascular disease.
• Balances fibroblast invasion and myofibroblast transition in lung injury and fibrosis.
• Supports bone regeneration through osteoimmunity-regulating scaffolds that promote ECM organization.
• Contributes to neuromuscular disorders through muscle satellite cell dysfunction and ECM remodeling.
• Drives perianal fistulizing Crohn's disease via mechanoregulated epithelial-to-mesenchymal transition.
• Regulates apical ECM organization during Drosophila embryonic salivary gland tube development.
• Promotes ROS-associated epithelial remodeling in laryngeal squamous cell carcinoma.
• Modulates pericellular proteolysis and tumor progression through matrix-directed signaling.
• Provides a mechanistic link between mechanical cues and gene expression programs.
• Serves as a functional annotation for CRISPR screens targeting ECM regulators.
What Happens During positive regulation of extracellular matrix organization?
Initiation by secreted and matricellular signals
In simple terms: Cells release signals that tell the matrix to build up.
Positive regulation of ECM organization begins when cells secrete or respond to matricellular proteins, growth factors, and cytokines that promote matrix assembly. For example, SFRP1 modulates lung fibroblast behavior during injury-induced myofibroblast transition, acting as a brake on invasive ECM remodeling. Matrix-directed pericellular proteolysis also generates bioactive fragments that feed back to enhance ECM organization.
Transcriptional control of ECM gene programs
In simple terms: Master transcription factors switch on the genes that make matrix components.
Transcription factors such as SOX9 positively regulate ECM organization by driving expression of collagens and other matrix genes, thereby altering ECM composition and stiffness in vascular aging. This transcriptional layer integrates developmental and stress signals into a coordinated ECM program.
Assembly and crosslinking of matrix components
In simple terms: Newly made matrix proteins are assembled and crosslinked into a stable network.
Once ECM genes are expressed, their protein products are secreted and assembled into fibrils and networks. Sulfation of matrix components affects apical ECM organization during Drosophila embryonic salivary gland tube development, showing that post-translational modifications are required for proper assembly.
Mechanical feedback and remodeling
In simple terms: The stiffening matrix pushes back on cells, reinforcing the building program.
As ECM organization increases, matrix stiffness rises and mechanically activates cells, creating a positive feedback loop. In perianal fistulizing Crohn's disease, dysfunctional ECM remodeling supports disease through a mechanoregulated activation of epithelial-to-mesenchymal transition. This feedback can sustain pathological ECM accumulation.
Integration with immune and metabolic signals
In simple terms: Immune cells and metabolism also influence how much matrix is built.
Osteoimmunity-regulating scaffolds promote bone regeneration by coordinating immune signals with ECM organization. In laryngeal squamous cell carcinoma, ACOT9 promotes ROS-associated epithelial remodeling, linking mitochondrial metabolism to ECM changes. These examples show that positive regulation of ECM organization is not cell-autonomous but integrates multiple physiological inputs.
Key Genes Involved in GO:1903055 positive regulation of extracellular matrix organization
The following genes and proteins have been experimentally linked to positive regulation of extracellular matrix organization in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOX9 | Transcription factor that drives ECM gene expression and stiffness | Vascular aging and ECM composition |
| SFRP1 | Modulates fibroblast invasion and myofibroblast transition | Lung injury and fibrosis |
| ACOT9 | Mitochondrial metabolism-related gene promoting ROS-associated epithelial remodeling | Laryngeal squamous cell carcinoma |
| MMPs (matrix metalloproteinases) | Pericellular proteolysis and matrix remodeling | Tumor progression and invasion |
| Integrins | Cell-matrix adhesion and mechanotransduction | ECM organization and signaling |
| Collagens | Major structural ECM proteins | ECM assembly and stiffness |
| Fibronectin | ECM glycoprotein that templates matrix assembly | Wound healing and fibrosis |
| TGF-beta | Cytokine that promotes myofibroblast differentiation and ECM deposition | Fibrosis and EMT |
| YAP/TAZ | Mechanotransducers that respond to matrix stiffness | ECM feedback and gene expression |
| EMT regulators | Control epithelial-to-mesenchymal transition | Fistulizing Crohn's disease |
| Satellite cell factors | Muscle stem cell function and ECM remodeling | Neuromuscular disorders |
| Sulfation enzymes | Post-translational modification of ECM components | Drosophila salivary gland tube development |
| Osteoimmunity modulators | Couple immune signals to bone ECM organization | Bone regeneration |
| Pericellular proteases | Generate bioactive matrix fragments | Tumor progression |
| Growth factors | Stimulate ECM gene expression | General ECM regulation |
How Is positive regulation of extracellular matrix organization Regulated?
Positive regulation of extracellular matrix organization is controlled at multiple levels. Transcriptional regulators such as SOX9 increase ECM gene expression, while secreted modulators like SFRP1 can inhibit fibroblast invasion and myofibroblast transition, thereby restraining excessive ECM organization. Mechanical feedback through matrix stiffness activates mechanotransduction pathways that reinforce ECM deposition. Metabolic and ROS-related signals, as shown for ACOT9, can also promote epithelial remodeling and ECM changes. Together, these layers ensure that ECM organization is responsive to injury, mechanical load, and metabolic state.
positive regulation of extracellular matrix organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOX9 | Vascular aging | Knockout and overexpression in vascular smooth muscle cells |
| SFRP1 | Lung fibrosis | Knockout in lung fibroblasts |
| ACOT9 | Laryngeal squamous cell carcinoma | Knockout in carcinoma cell lines |
| MMPs | Tumor progression | Point mutation and knockout in cancer cells |
| EMT regulators | Fistulizing Crohn's disease | Knock-in reporters in intestinal epithelial cells |
Vascular aging and cardiovascular disease
SOX9 accelerates vascular aging by regulating ECM composition and stiffness, demonstrating that positive regulation of ECM organization directly contributes to age-related vascular dysfunction. Targeting this axis may reduce arterial stiffening.
Lung fibrosis and fibroblast invasion
SFRP1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts, indicating that loss of this inhibitory control can unleash excessive ECM organization and fibrosis.
Perianal fistulizing Crohn's disease
Dysfunctional ECM remodeling supports perianal fistulizing Crohn's disease through a mechanoregulated activation of epithelial-to-mesenchymal transition, linking positive ECM regulation to chronic inflammatory disease.
Cancer progression and epithelial remodeling
Matrix-directed pericellular proteolysis and tumor progression are closely linked, and ACOT9 promotes ROS-associated epithelial remodeling in laryngeal squamous cell carcinoma, showing that positive ECM regulation supports tumor invasion.
From positive regulation of extracellular matrix organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate ECM organization? | CRISPR knockout in relevant cell type |
| Does a specific point mutation alter ECM regulation? | Point mutation knock-in |
| Does tagging a candidate gene affect its function? | Tagged knock-in |
| Does overexpression increase ECM deposition? | Overexpression cell model |
| Which genes regulate ECM organization in a genome-wide screen? | CRISPR library screening |
| How does matrix stiffness feed back on gene expression? | Mechanotransduction reporter model |
How to Study the positive regulation of extracellular matrix organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of ECM genes | Identify positive regulators |
| Proteomics | ECM protein composition | Quantify matrix deposition |
| Confocal microscopy | Matrix structure and organization | Visualize ECM assembly |
| Invasion assay | Fibroblast invasive capacity | Assess ECM remodeling |
| Collagen gel contraction | Cell-mediated matrix contraction | Measure functional ECM regulation |
| CRISPR screen | Genes affecting ECM organization | Genome-wide discovery |
| Mechanotransduction reporter | Stiffness-responsive signaling | Study feedback loops |
Transcriptomic profiling
RNA-seq can identify ECM genes and regulators whose expression changes upon perturbation of candidate positive regulators.
Proteomic and secretome analysis
Mass spectrometry of secreted proteins measures ECM component deposition and composition changes.
Imaging of ECM organization
Confocal and electron microscopy visualize matrix assembly, fibril structure, and stiffness-related changes.
Functional invasion and contraction assays
Fibroblast invasion and collagen gel contraction assays quantify the functional output of positive ECM regulation.
How CRISPR Can Be Used to Study GO:1903055 positive regulation of extracellular matrix organization
Knockout
CRISPR knockout of candidate genes such as SOX9 or SFRP1 can test whether they are required for positive regulation of ECM organization in disease-relevant cells.
Point Mutation
Point mutation knock-in can model specific amino acid changes that alter ECM regulatory activity, as illustrated by scaffold-based bone regeneration studies.
Knock-in
Tagged knock-in of ECM components or regulators allows tracking of protein localization and dynamics during matrix assembly.
Overexpression
Overexpression of genes such as ACOT9 can test sufficiency for promoting ECM organization and epithelial remodeling.
How EDITGENE Supports positive regulation of extracellular matrix organization Research
Researchers studying positive regulation of extracellular matrix organization-related genes often need to determine whether a candidate gene is causally involved in ECM assembly, deposition, or remodeling. EDITGENE provides the CRISPR cell models and screening services required to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of extracellular matrix organization research.
Frequently Asked Questions About positive regulation of extracellular matrix organization
What is GO:1903055?
GO:1903055 is the Gene Ontology term for positive regulation of extracellular matrix organization, meaning any process that activates or increases the frequency, rate or extent of ECM organization.
What genes are involved in positive regulation of extracellular matrix organization?
Genes such as SOX9, SFRP1, ACOT9, MMPs, and integrins have been linked to positive regulation of ECM organization.
How does SOX9 regulate extracellular matrix organization?
SOX9 accelerates vascular aging by regulating ECM composition and stiffness, acting as a positive regulator.
What is the role of SFRP1 in lung fibrosis?
SFRP1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts, restraining excessive ECM organization.
How is ECM organization studied with CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators.
What diseases involve positive regulation of ECM organization?
Vascular aging, lung fibrosis, perianal fistulizing Crohn's disease, and cancer progression all involve dysregulated positive ECM regulation.
What methods measure ECM organization?
RNA-seq, proteomics, confocal microscopy, invasion assays, and collagen gel contraction are commonly used.
Can CRISPR screens identify ECM regulators?
Yes, CRISPR library screening can discover genes that positively regulate ECM organization.
What is the difference between ECM organization and its positive regulation?
ECM organization is the process of matrix assembly; positive regulation describes inputs that increase its frequency, rate, or extent.
How does mechanical stiffness affect ECM regulation?
Matrix stiffness can mechanically activate cells and reinforce ECM deposition through feedback loops.
Conclusion
GO:1903055, positive regulation of extracellular matrix organization, captures the regulatory inputs that increase ECM assembly and remodeling. It is central to development, repair, and major diseases including vascular aging, fibrosis, and cancer. CRISPR-based models and screens are essential tools for dissecting these mechanisms and identifying therapeutic targets. EDITGENE offers comprehensive services to support such research.
References
- 1. Faleeva M et al.. 2024. Sox9 Accelerates Vascular Aging by Regulating Extracellular Matrix Composition and Stiffness.. Circ Res 134(3):307-324 PMID: 38179698
- 2. Mayr CH et al.. 2024. Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts.. Eur Respir J 63(2) PMID: 38212077
- 3. Zhang J et al.. 2022. Osteoimmunity-Regulating Biomimetically Hierarchical Scaffold for Augmented Bone Regeneration.. Adv Mater 34(36):e2202044 PMID: 35785450
- 4. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 5. Rizzo G et al.. 2023. Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition.. Cell Mol Gastroenterol Hepatol 15(3):741-764 PMID: 36521659
- 6. Woodward JL et al.. 2025. Sulfation affects apical extracellular matrix organization during development of the Drosophila embryonic salivary gland tube.. Elife 14 PMID: 40985336
- 7. Wang W et al.. 2026. ACOT9, a mitochondrial metabolism-related gene, promotes ROS-associated epithelial remodeling in laryngeal squamous cell carcinoma.. J Transl Med 24(1) PMID: 42343374
- 8. Hornebeck W et al.. 2002. Matrix-directed regulation of pericellular proteolysis and tumor progression.. Semin Cancer Biol 12(3):231-41 PMID: 12083853
